The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 31, 2026
Snapshot (as of Aug 31, 2026): AbbVie Inc. (ABBV) pays a $6.83 annual dividend ($1.73 quarterly), yielding 2.67% at $255.48/share. Next ex-dividend date 2026-07-15. 11+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.67%
Annual Dividend: $6.83 per share
Payout Ratio: 189.7% (based on depressed trailing earnings — see safety analysis below)
Ex-Dividend Date: 2026-07-15
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 14
AbbVie Inc. pays a $6.83 per share annual dividend, making the AbbVie Inc. dividend one of the more notable income streams in the healthcare sector. ABBV currently yields 2.67%, paid quarterly, with the next ex-dividend date on July 15, 2026. The last dividend payment was $1.73 per share. With a beta of 0.28, ABBV stock moves far less than the broader market, which suits income investors who prioritize low price volatility over capital gains.
AbbVie Inc. pays out 189.7% of earnings as dividends, a payout ratio classified as high (above 75%). That figure is elevated, but the company's portfolio spans essential, recurring-demand therapies: HUMIRA for autoimmune conditions, SKYRIZI for plaque psoriasis, and RINVOQ for rheumatoid arthritis, all of which generate ongoing prescription revenue. AbbVie Inc. dividend safety hinges on whether that product revenue continues to cover the gap between earnings and the declared payout. The primary pressure point is that a payout ratio above 100% means the dividend currently exceeds reported earnings, leaving little room for an earnings shortfall.
AbbVie Inc. dividend history shows a CAGR of 12.5% per year from 2013 to 2025. The per-share dividend grew from $1.60 to $6.56 over that window (2026 data is a partial year and excluded from the growth calculation). The smallest annual increase in the window was 3.7% in 2014, while the largest single-year jump reached 40.2% in 2018. At 12.5% annualized, the growth rate is fast enough to meaningfully compound income over time, even if the pace has moderated in recent years.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +5.2% | $5.64 (2022) | $6.56 (2025) |
| 5-Year | +6.8% | $4.72 (2020) | $6.56 (2025) |
| 10-Year | +12.5% | $2.02 (2015) | $6.56 (2025) |
ABBV stock fits dividend investors who want a combination of above-average income and a long history of annual increases. The yield sits at 2.67%, classified as moderate (2–4%), and runs above the 5-year average yield of 2.31%, meaning the current entry point offers more income than the historical norm. Eleven consecutive years of dividend increases back that income with a clear pattern of growth. The trade-off is a payout ratio of 189.7%, which means the dividend is not covered by current earnings. Income investors get a growing, quarterly-paying dividend anchored in a diversified pharmaceutical business, but they accept meaningful payout ratio risk in exchange.
| Payment Date | Amount per Share |
|---|---|
| 2026-07-15 | $1.7300 |
| 2026-04-15 | $1.7300 |
| 2026-01-16 | $1.7300 |
| 2025-10-15 | $1.6400 |
| 2025-07-15 | $1.6400 |
| 2025-04-15 | $1.6400 |
| 2025-01-15 | $1.6400 |
| 2024-10-15 | $1.5500 |
| 2024-07-15 | $1.5500 |
| 2024-04-12 | $1.5500 |
| Year | Total Dividends |
|---|---|
| 2026 | $5.1900 |
| 2025 | $6.5600 |
| 2024 | $6.2000 |
| 2023 | $5.9200 |
| 2022 | $5.6400 |
Project income from ABBV with the ABBV dividend calculator or track your full portfolio with the dividend tracker.